For millions of people living with HIV, a daily regimen of medications is a lifelong necessity. If they stop taking the drugs ...
Funding from the Gates Foundation supports development of multiple in vivo Gene Writing strategies aimed at enabling a scalable cure for HIVSOMERVILLE, Mass., March 23, 2026 (GLOBE NEWSWIRE) -- ...
Imagine a game of chess where your opponent's king is in check. It cannot move, but the game is not over—the piece remains on ...
A novel regimen of doravirine and islatravir was noninferior to a common HIV therapy as an initial HIV treatment, according ...
Findings identify genes that may represent possible new targets for a "block and lock" strategy for curing HIV.
Add Yahoo as a preferred source to see more of our stories on Google. A new single-pill HIV treatment has proved as effective as regimens of up to 11 tablets a day in suppressing the virus in ...
– Investigational Long-Acting, Twice-Yearly Treatment Regimen of Lenacapavir and Broadly Neutralizing Antibodies (bNAbs) Meets Primary Endpoint in Phase 2 Study and Gains Breakthrough Therapy ...
Benjamin K. Chen, MD, PhD, discussed the next steps after the results of his study in genetic tagging showed promise in targeting HIV cells. How do you envision gene therapy working with other forms ...
A Q&A With Shauna Applin, ARNP. AJMC: Despite substantial therapeutic advances since the 1980s, the US is not on pace to achieve the goals of the Ending the HIV Epidemic (EHE) public health initiative ...
A wave of under-the-radar HIV policy changes is unfolding nationwide, with advocates warning of serious, far-reaching consequences.
What are the three types of HIV tests available to patients, how do they differ, and how can patients determine the best ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results